Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/ L211A) by intradermal immunization in mice

Milton Maciel, Mark Smith, Steven T. Poole, Renee M. Laird, Julianne E. Rollenhagen, Robert W. Kaminski, Heather Wenzel, A. Louis Bourgeois, Stephen J. Savarino

Research output: Contribution to journalArticle

Abstract

The development of an effective subunit vaccine is frequently complicated by the difficulty of eliciting protective immune responses, often requiring the co-administration of an adjuvant. Heat-labile toxin (LT), an enterotoxin expressed by enterotoxigenic E. coli (ETEC) with an AB5 structure similar to cholera toxin, is a strong adjuvant. While the mucosa represents the natural route of exposure to LT and related toxins, the clinical utility of LT and similar adjuvants given by mucosal routes has been limited by toxicity, as well as the association between intranasal delivery of LT and Bell’s palsy. Single and double amino acid mutants of LT, LT(R192G)/mLT and LT(R192G/L211A)/dmLT respectively, have been proposed as alternatives to reduce the toxicity associated with the holotoxin. In the present study, we compared mLT and dmLT given via a non-mucosal route (i.e. intradermally) to investigate their adjuvanticity when co-administrated with an enterotoxigenic E. coli vaccine candidate, CfaEB. Antigenicity (i.e. ability to elicit response against LT) and reactogenicity at the injection site were also evaluated. BALB/c mice were immunized by the intradermal route with CfaEB plus increasing doses of either mLT or dmLT (0.01 to 2.5 μg). Both adjuvants induced dose-dependent skin reactogenicity, with dmLT being less reactogenic than mLT. Both adjuvants significantly boosted the anti-CfaE IgG and functional hemagglutination inhibiting (HAI) antibody responses, compared to the antigen alone. In addition to inducing anti-LT responses, even at the lowest dose tested (0.01 μg), the adjuvants also prompted in vitro cytokine responses (IFN-γ, IL-4, IL-5, IL-10 and IL-17) that followed different patterns, depending on the protein used for stimulation (CfaE or LTB) and/or the dose used for immunization. The two LT mutants evaluated here, mLT and dmLT, are potent adjuvants for intradermal immunization and should be further investigated for the intradermal delivery of subunit ETEC vaccines.

Original languageEnglish (US)
Article numbere0224073
JournalPloS one
Volume14
Issue number11
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Escherichia coli Vaccines
Immunization
Enterotoxigenic Escherichia coli
Toxicity
immunization
toxins
Subunit Vaccines
Interleukin-17
adjuvants
Enterotoxins
Cholera Toxin
Interleukin-5
mice
Interleukin-4
Interleukin-10
Escherichia coli
Bell Palsy
Skin
Immunoglobulin G
Hemagglutination

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Maciel, M., Smith, M., Poole, S. T., Laird, R. M., Rollenhagen, J. E., Kaminski, R. W., ... Savarino, S. J. (2019). Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/ L211A) by intradermal immunization in mice. PloS one, 14(11), [e0224073]. https://doi.org/10.1371/journal.pone.0224073

Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/ L211A) by intradermal immunization in mice. / Maciel, Milton; Smith, Mark; Poole, Steven T.; Laird, Renee M.; Rollenhagen, Julianne E.; Kaminski, Robert W.; Wenzel, Heather; Bourgeois, A. Louis; Savarino, Stephen J.

In: PloS one, Vol. 14, No. 11, e0224073, 01.01.2019.

Research output: Contribution to journalArticle

Maciel, M, Smith, M, Poole, ST, Laird, RM, Rollenhagen, JE, Kaminski, RW, Wenzel, H, Bourgeois, AL & Savarino, SJ 2019, 'Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/ L211A) by intradermal immunization in mice', PloS one, vol. 14, no. 11, e0224073. https://doi.org/10.1371/journal.pone.0224073
Maciel, Milton ; Smith, Mark ; Poole, Steven T. ; Laird, Renee M. ; Rollenhagen, Julianne E. ; Kaminski, Robert W. ; Wenzel, Heather ; Bourgeois, A. Louis ; Savarino, Stephen J. / Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/ L211A) by intradermal immunization in mice. In: PloS one. 2019 ; Vol. 14, No. 11.
@article{f709cb48fd5e443187da9d0f3278b31e,
title = "Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/ L211A) by intradermal immunization in mice",
abstract = "The development of an effective subunit vaccine is frequently complicated by the difficulty of eliciting protective immune responses, often requiring the co-administration of an adjuvant. Heat-labile toxin (LT), an enterotoxin expressed by enterotoxigenic E. coli (ETEC) with an AB5 structure similar to cholera toxin, is a strong adjuvant. While the mucosa represents the natural route of exposure to LT and related toxins, the clinical utility of LT and similar adjuvants given by mucosal routes has been limited by toxicity, as well as the association between intranasal delivery of LT and Bell’s palsy. Single and double amino acid mutants of LT, LT(R192G)/mLT and LT(R192G/L211A)/dmLT respectively, have been proposed as alternatives to reduce the toxicity associated with the holotoxin. In the present study, we compared mLT and dmLT given via a non-mucosal route (i.e. intradermally) to investigate their adjuvanticity when co-administrated with an enterotoxigenic E. coli vaccine candidate, CfaEB. Antigenicity (i.e. ability to elicit response against LT) and reactogenicity at the injection site were also evaluated. BALB/c mice were immunized by the intradermal route with CfaEB plus increasing doses of either mLT or dmLT (0.01 to 2.5 μg). Both adjuvants induced dose-dependent skin reactogenicity, with dmLT being less reactogenic than mLT. Both adjuvants significantly boosted the anti-CfaE IgG and functional hemagglutination inhibiting (HAI) antibody responses, compared to the antigen alone. In addition to inducing anti-LT responses, even at the lowest dose tested (0.01 μg), the adjuvants also prompted in vitro cytokine responses (IFN-γ, IL-4, IL-5, IL-10 and IL-17) that followed different patterns, depending on the protein used for stimulation (CfaE or LTB) and/or the dose used for immunization. The two LT mutants evaluated here, mLT and dmLT, are potent adjuvants for intradermal immunization and should be further investigated for the intradermal delivery of subunit ETEC vaccines.",
author = "Milton Maciel and Mark Smith and Poole, {Steven T.} and Laird, {Renee M.} and Rollenhagen, {Julianne E.} and Kaminski, {Robert W.} and Heather Wenzel and Bourgeois, {A. Louis} and Savarino, {Stephen J.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1371/journal.pone.0224073",
language = "English (US)",
volume = "14",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/ L211A) by intradermal immunization in mice

AU - Maciel, Milton

AU - Smith, Mark

AU - Poole, Steven T.

AU - Laird, Renee M.

AU - Rollenhagen, Julianne E.

AU - Kaminski, Robert W.

AU - Wenzel, Heather

AU - Bourgeois, A. Louis

AU - Savarino, Stephen J.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The development of an effective subunit vaccine is frequently complicated by the difficulty of eliciting protective immune responses, often requiring the co-administration of an adjuvant. Heat-labile toxin (LT), an enterotoxin expressed by enterotoxigenic E. coli (ETEC) with an AB5 structure similar to cholera toxin, is a strong adjuvant. While the mucosa represents the natural route of exposure to LT and related toxins, the clinical utility of LT and similar adjuvants given by mucosal routes has been limited by toxicity, as well as the association between intranasal delivery of LT and Bell’s palsy. Single and double amino acid mutants of LT, LT(R192G)/mLT and LT(R192G/L211A)/dmLT respectively, have been proposed as alternatives to reduce the toxicity associated with the holotoxin. In the present study, we compared mLT and dmLT given via a non-mucosal route (i.e. intradermally) to investigate their adjuvanticity when co-administrated with an enterotoxigenic E. coli vaccine candidate, CfaEB. Antigenicity (i.e. ability to elicit response against LT) and reactogenicity at the injection site were also evaluated. BALB/c mice were immunized by the intradermal route with CfaEB plus increasing doses of either mLT or dmLT (0.01 to 2.5 μg). Both adjuvants induced dose-dependent skin reactogenicity, with dmLT being less reactogenic than mLT. Both adjuvants significantly boosted the anti-CfaE IgG and functional hemagglutination inhibiting (HAI) antibody responses, compared to the antigen alone. In addition to inducing anti-LT responses, even at the lowest dose tested (0.01 μg), the adjuvants also prompted in vitro cytokine responses (IFN-γ, IL-4, IL-5, IL-10 and IL-17) that followed different patterns, depending on the protein used for stimulation (CfaE or LTB) and/or the dose used for immunization. The two LT mutants evaluated here, mLT and dmLT, are potent adjuvants for intradermal immunization and should be further investigated for the intradermal delivery of subunit ETEC vaccines.

AB - The development of an effective subunit vaccine is frequently complicated by the difficulty of eliciting protective immune responses, often requiring the co-administration of an adjuvant. Heat-labile toxin (LT), an enterotoxin expressed by enterotoxigenic E. coli (ETEC) with an AB5 structure similar to cholera toxin, is a strong adjuvant. While the mucosa represents the natural route of exposure to LT and related toxins, the clinical utility of LT and similar adjuvants given by mucosal routes has been limited by toxicity, as well as the association between intranasal delivery of LT and Bell’s palsy. Single and double amino acid mutants of LT, LT(R192G)/mLT and LT(R192G/L211A)/dmLT respectively, have been proposed as alternatives to reduce the toxicity associated with the holotoxin. In the present study, we compared mLT and dmLT given via a non-mucosal route (i.e. intradermally) to investigate their adjuvanticity when co-administrated with an enterotoxigenic E. coli vaccine candidate, CfaEB. Antigenicity (i.e. ability to elicit response against LT) and reactogenicity at the injection site were also evaluated. BALB/c mice were immunized by the intradermal route with CfaEB plus increasing doses of either mLT or dmLT (0.01 to 2.5 μg). Both adjuvants induced dose-dependent skin reactogenicity, with dmLT being less reactogenic than mLT. Both adjuvants significantly boosted the anti-CfaE IgG and functional hemagglutination inhibiting (HAI) antibody responses, compared to the antigen alone. In addition to inducing anti-LT responses, even at the lowest dose tested (0.01 μg), the adjuvants also prompted in vitro cytokine responses (IFN-γ, IL-4, IL-5, IL-10 and IL-17) that followed different patterns, depending on the protein used for stimulation (CfaE or LTB) and/or the dose used for immunization. The two LT mutants evaluated here, mLT and dmLT, are potent adjuvants for intradermal immunization and should be further investigated for the intradermal delivery of subunit ETEC vaccines.

UR - http://www.scopus.com/inward/record.url?scp=85074372525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074372525&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0224073

DO - 10.1371/journal.pone.0224073

M3 - Article

C2 - 31682624

AN - SCOPUS:85074372525

VL - 14

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 11

M1 - e0224073

ER -